Results

Total Results: 2,204 records

Showing results for "drugs".

161. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The search is on for ways to definitively diagnose AD and for drugs, biologics, and alternative or … The Horizon Scanning System is tracking several drugs in late-phase development. … CNS Drugs. 2013 Jul;27(7):505-14. PMID: 23719722 5. Reger MA, Watson GS, Green PS, et al.

162. Diabetes Mellitus (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
     March 01, 2012 - for development of exenatide, leaving sole development responsibility to Amylin Pharmaceuticals. … No major hypoglycemia events occurred. 47 In July 2011, Amylin Pharmaceuticals, Eli Lilly, and … Drugs Future 2008;33(9):745-51. 74. … Selected pharmaceuticals in late stage U.S. and E.U. development or registration. … The Woodlands (TX): Lexicon Pharmaceuticals; [accessed 2011 May 23]. [1 p].

163. Treatment of Depression During Pregnancy and the Postpartum Period | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/depression-pregnancy-postpartum/research-protocol
     December 01, 2019 - Coadministration of other psychoactive drugs, specifically, antipsychotics, antianxiety agents (e.g., … benzodiazepines), and drugs for insomnia? … Interventions Interventions include commonly used antidepressant drugs. … Drugs not listed below will not be included (e.g., monoamine oxidase inhibitors). Table 1. … The drugs listed above in Table 1 when compared with each other.

164. Topic 0590 Strategies to Treat and Manage Infantile Hemangioma NSD FINAL_SJ (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0715-140408.pdf
     April 08, 2014 - Comparator(s): Systemic (enteral) medical therapy using corticosteroids, medical therapy using cytostatic drugs … infantile hemangioma as compared to other medical interventions, including corticosteroids, cytostatic drugs

165. Comparative Effectiveness and Safety: Emerging Methods - Part I | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/safety-emerging-methods/overview
     November 01, 2017 - Assessment of Adherence to and Persistence on Disease-Modifying Antirheumatic Drugs (DMARDs) in Patients … Assessment of Adherence to and Persistence on Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Patients … Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic … Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic

166. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - (Morrisville, NC), a subsidiary of Valeant Pharmaceuticals International, Inc. … Raleigh (NC): Salix Pharmaceuticals, Inc. 2014 Mar. 19 p. 5. … Raleigh (NC): Salix Pharmaceuticals, Ltd.; 2014 Oct 21 [accessed 2015 Feb 11]. [5 p]. … Salix Pharmaceuticals, Inc. … Raliegh (NC): Salix Pharmaceuticals, Inc.; 2015 May. 7 p.

167. S66 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s66.pdf
     October 01, 2007 - ORIGINAL ARTICLE Assessment of Adherence to and Persistence on Disease-Modifying Antirheumatic Drugs … Griffin, MD, MPH*§¶ Objective: Biologic disease-modifying antirheumatic drugs (DMARDs) are efficacious … The discontinuation of either of the drugs determined the end of the episode. … The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature … New drugs for rheumatoid arthritis. N Engl J Med. 2004;350:2167–2179. 43.

168. Comparative Effectiveness of Medications in Patients with Epilepsy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_disposition-comments.pdf
     March 01, 2012 - This is seldom an issue for antiepileptic drugs unless they are given intraveneously. … However, when we looked at the newer drugs actually compared, there are only but a few newer drugs … Each of these properties clearly impacts the effective selection and use of these drugs. … The problem of pharmacokinetic interactions of other drugs with antiepileptic drugs is important to … - lowering drugs.

169. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
     December 01, 2010 - Antipsychotic drugs, neurotransmitters, and Schizophrenia. … New drugs for the treatment of schizophourenic patients. … Developing novel antipsychotic drugs: strategies and goals. … Effectiveness of antipsychotic drugs in patients with chouronic Schizophrenia. … Comparative effectiveness of antipsychotic drugs.

170. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0477_11-01-2011.pdf
     January 01, 2011 - The nominator is also concerned with adverse side effects of pharmaceuticals used to treat fibromyalgia … (e.g., cyclobenzaprine); simple analgesics; opioid analgesics (e.g., tramadol); anti-inflammatory drugs

171. For patients with Crohn's disease, what treatments or therapies, alone or in conjunction with one another, provide the highest rate of disease management with the lowest risk of long term complications, particularly in young women? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-patients-with-crohns-disease-what-treatments-or-therapies-alone-or-in-conjunction-with-one-another-provide-the-highest-rate-of-disease-management-with-the-lowest-risk-of-long-term-complications-particularly-in-young-wome
     November 01, 2017 - yes If yes, explain the specific technologies, devices, drugs, or interventions you would like to … Any additional evidence will provide peace of mind as well as potential financial relief since the drugs … Any additional evidence will provide peace of mind as well as potential financial relief since the drugs

172. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
     October 01, 2011 - work loss.3, 4 Common oral medications for osteoarthritis include nonsteroidal anti- inflammatory drugs … Food and Drug Administration (FDA) as pharmaceuticals, including glucosamine and chondroitin.5 Opioid … In addition, benefits and harms may vary for individual drugs within a class. … Non-steroidal anti- inflammatory drugs. … Non- steroidal anti-inflammatory drugs for low-back pain.

173. S58 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s58.pdf
     October 01, 2007 - powerful and under-used resource for health services research on the use and outcomes of prescription drugs … Key Words: Medicaid, prescription drugs, methodology, claims, outcomes, adherence (Med Care 2007;45: … Whereas participants in randomized clinical trials (RCTs) of drugs sometimes fail to represent the full … Examination of which beneficiaries use which drugs is simply a starting point; further insight can be … while hospitalized, over- the-counter drugs, and nonformulary drugs purchased out-of- pocket.28 Many

174. Acute Treatments for Episodic Migraine | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/migraine-treatments/research
     January 01, 2023 - Compared with placebo, treatments such as triptans, NSAIDs (nonsteroidal anti-inflammatory drugs … Some opioids may be less effective than other drugs. … Comparative effectiveness evidence about triptans and nonsteroidal anti-inflammatory drugs (NSAIDs) was

175. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Combination phentermine-topiramate (Qsymia®, Vivus, Inc., Mountain View, CA)  Lorcaserin (Belviq®, Arena Pharmaceuticals … Phentermine-topiramate is a controlled-release formulation of two separate FDA-approved drugs. … Arena Pharmaceuticals and Eisai announce FDA approval of Belviq (lorcaserin HCl) for chronic weight … San Diego (CA): Arena Pharmaceuticals; 2012 Jun 27 [accessed 2012 Jul 5]. [4 p].

176. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
     January 01, 2012 - For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the four topics for which (1) preliminary phase III data for drugs and … Most research activity in this priority area is focusing on drugs and biologics for irritable bowel … Curr Opin Investig Drugs 2001 Apr;2(4):505-9. PMID: 11566007 43. Tappenden K, Edelman J.

177. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
     January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … below lists the three topics for which (1) preliminary phase III or later data were available for drugs … The experts stated oral treprostinil could be used more frequently than other drugs to treat patients

178. Changing Patterns of Medication Use in Patients With Rheumatoid Arthritis in a Medicaid Population | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-1/research
     January 01, 2020 - Annual age-specific utilization of DMARDs, glucocorticoids, non-steroidal anti-inflammatory drugs (NSAIDs … rheumatoid arthritis, disease modifying anti-rheumatic drugs, epidemiology. … Introduction The treatment of rheumatoid arthritis (RA) with disease modifying anti-rheumatic drugs … Interestingly, about 10% of patients were not using any study drugs on the index dates. … The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from

179. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
     March 01, 2009 - first reported higher mortality in elderly patients taking haloperidol compared with two atypical drugs … FDA warns antipsychotic drugs may be risky for elderly. JAMA 2005 May 25;293(20):2462. 3. … Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using … Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. … Antipsychotic drugs in dementia: what should be made of the risks?

180. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
     January 28, 2016 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … unmet need for new antiviral drugs for treating chronic HCV infection. … Manufacturers with the most advanced candidates include the Janssen Pharmaceuticals unit of Johnson … It excluded 72 drugs in 2015, including Harvoni, Sovaldi, and Olysio. … Available: http://blue.regence.com/trgmedpol/drugs/dru366 .pdf. 91.